News Update Detailed Results From Biogen

News Update Detailed Results From Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA™ (Daclizumab High-Yield Process) http://ow.ly/2NqhG0

Advertisements